These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18314381)

  • 1. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: the DESIRE study.
    Cazeau SJ; Daubert JC; Tavazzi L; Frohlig G; Paul V
    Eur J Heart Fail; 2008 Mar; 10(3):273-80. PubMed ID: 18314381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.
    Yu CM; Chan YS; Zhang Q; Yip GW; Chan CK; Kum LC; Wu L; Lee AP; Lam YY; Fung JW
    J Am Coll Cardiol; 2006 Dec; 48(11):2251-7. PubMed ID: 17161255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy.
    Oyenuga O; Hara H; Tanaka H; Kim HN; Adelstein EC; Saba S; Gorcsan J
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):132-40. PubMed ID: 20159638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
    Gasparini M; Regoli F; Galimberti P; Ceriotti C; Bonadies M; Mangiavacchi M; Andreuzzi B; Bragato R; Pini D; Klersy C; Gronda E
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S34-9. PubMed ID: 17302713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.
    Eldadah ZA; Rosen B; Hay I; Edvardsen T; Jayam V; Dickfeld T; Meininger GR; Judge DP; Hare J; Lima JB; Calkins H; Berger RD
    Heart Rhythm; 2006 Apr; 3(4):435-42. PubMed ID: 16567291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of cardiac resynchronisation therapy in patients with echocardiographic evidence of mechanical dyssynchrony.
    Achilli A; Sassara M; Pontillo D; Turreni F; Rossi P; De Luca R; Klersy C; Patruno N; Achilli P; Sallusti L; Spadaccia P; Cricco L; Serra F
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):131-6. PubMed ID: 18192804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Chan CK; Chan YS; Zhang Q; Lin H; Yip GW; Kum LC; Kong SL; Zhang Y; Sanderson JE
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1058-65. PubMed ID: 15363081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial.
    Gorcsan J; Sogaard P; Bax JJ; Singh JP; Abraham WT; Borer JS; Dickstein K; Gras D; Krum H; Brugada J; Robertson M; Ford I; Holzmeister J; Ruschitzka F
    Eur Heart J; 2016 Jan; 37(1):49-59. PubMed ID: 26321238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to cardiac resynchronization therapy: the selection of candidates for CRT (SCART) study.
    Achilli A; Peraldo C; Sassara M; Orazi S; Bianchi S; Laurenzi F; Donati R; Perego GB; Spampinato A; Valsecchi S; Denaro A; Puglisi A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S11-9. PubMed ID: 17169127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.